tiprankstipranks
Trending News
More News >
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market

Halozyme (HALO) Technical Analysis

Compare
1,014 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
6Neutral
12Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Halozyme Therapeutics’s (HALO) Moving Averages Convergence Divergence (MACD) indicator is -1.33, suggesting Halozyme Therapeutics is a Sell.
Halozyme Therapeutics’s (HALO) 20-Day exponential moving average is 55.29, while Halozyme Therapeutics’s (HALO) share price is $54.25, making it a Sell.
Halozyme Therapeutics’s (HALO) 50-Day exponential moving average is 57.14, while Halozyme Therapeutics’s (HALO) share price is $54.25, making it a Sell.

Halozyme (HALO) Pivot Points

Jun 08, 2025, 01:29 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
52.06
52.64
53.09
53.67
54.12
54.70
55.15
Fibonacci
52.64
53.03
53.27
53.67
54.06
54.30
54.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (HALO) Moving Averages

Jun 08, 2025, 01:29 AM
Period
Simple
Exponential
MA5
54.12Buy
54.12Buy
MA10
54.48Sell
54.37Sell
MA20
54.54Sell
55.29Sell
MA50
58.42Sell
57.14Sell
MA100
58.56Sell
57.30Sell
MA200
56.26Sell
56.19Sell
Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 54.37, while Halozyme Therapeutics’s (HALO) share price is $54.25, making it a Sell.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 57.30, while Halozyme Therapeutics’s (HALO) share price is $54.25, making it a Sell.
Halozyme Therapeutics’s (HALO) stock price is $54.25 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 58.42, creating a Sell signal.
Halozyme Therapeutics’s (HALO) stock price is $54.25 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 58.56, creating a Sell signal.
Halozyme Therapeutics’s (HALO) stock price is $54.25 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 56.26, creating a Sell signal.

Halozyme (HALO) Technical Indicators

Jun 08, 2025, 01:29 AM
Name
Value
Implied Action
RSI (14)
45.25
Neutral
STOCH (9,6)
31.51
Neutral
STOCHRSI (14)
62.62
Neutral
MACD (12,26)
-1.33
Sell
ADX (14)
20.74
Neutral
Williams %R
-46.12
Buy
CCI (14)
-10.79
Neutral
ATR (14)
2.35
-
Ultimate Oscillator
56.47
Neutral
ROC
4.29
Buy
Halozyme Therapeutics’s (HALO) Relative Strength Index (RSI) is 45.25, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Trend Strength Indicator (ADX) is 20.74, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Commodity Channel Index (CCI) is -10.79, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Price Rate of Change (ROC) is 4.29, creating a Buy signal.

FAQ

Is HALO a Buy, Hold, or Sell?
Based on HALO’s technical indicators, HALO is a Sell.
    What is HALO’s RSI (14)?
    HALO’s RSI (14) is 45.25, which suggests HALO is a Neutral.
      What is HALO’s MACD?
      HALO’s MACD is -1.33, which suggests HALO is a Sell.
        What is HALO’s 5-day moving average?
        HALO’s 5-day moving average is 54.12, which suggests HALO is a Buy.
          What is HALO’s 20-day moving average?
          HALO 20-day moving average is 54.54, which suggests HALO is a Sell.
            What is HALO’s 50-day moving average?
            HALO’s 50-day moving average is 58.42, which suggests HALO is a Sell.
              What is HALO’s 200-day moving average?
              HALO’s 200-day moving average is 56.26, which suggests HALO is a Sell.
                What is HALO’s Williams % R (14)?
                HALO’s Williams % R (14) is -46.12, which suggests HALO is a Buy.
                  What is HALO’s CCI (14)?
                  HALO’s CCI (14) is -10.79, which suggests HALO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis